|
2024
|
Invention
|
Methods of treating conditions related to the s1p1 receptor.
Provided are methods of treatment o... |
|
2023
|
Invention
|
Crystalline l-arginine salt of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3, 4-tet... |
|
|
Invention
|
Methods of treament.
Provided herein are treatment methods including administering a 5-hydroxytr... |
|
|
Invention
|
Methods of treatment. 2C2CRhihi]indole-8-carboxamide (Compound 1), or a pharmaceutically acceptab... |
|
|
Invention
|
Method of treating conditions related to the pgi2 receptor.
Provided in some embodiments are tit... |
|
|
Invention
|
Compositions comprising pgi2-receptor agonists and processes for the preparation thereof.
Provid... |
|
|
Invention
|
Methods of treatment.
Provided in some embodiments are methods of treating or preventing Raynaud... |
|
|
Invention
|
Methods of treating atopic dermatitis with etrasimod. Described herein are methods for treating a... |
|
|
Invention
|
Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related ther... |
|
|
Invention
|
Methods of treatment.
Provided is a method of treatment of a 5-hydroxytryptamine (HT)2C receptor... |
|
|
Invention
|
Methods of treatment. 2C Rhihi]indole-8-carboxamide (Compound (1)), or a pharmaceutically accepta... |
|
|
Invention
|
Novel s1p1 receptor agonist, crystalline salts, processes for preparing, and uses related thereto... |
|
|
Invention
|
Etrasimod for use in treating s1p1 receptor-associated disorders in combination with hormone trea... |
|
2022
|
Invention
|
Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful ... |
|
|
Invention
|
Compounds and methods for treatment of primary biliary cholangitis.
The present invention relate... |
|
|
Invention
|
Crystalline forms and processes for the preparation of pyrimidine derivatives useful as modulator... |
|
|
Invention
|
2a serotonin receptor. NN-(3-(4,6-dimethylpyrimidin-5-yl)-4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)cyc... |
|
|
Invention
|
Compounds and methods for treatment of inflammatory bowel disease with extra-intestinal manifesta... |
|
|
Invention
|
Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of disorders ... |
|
|
Invention
|
Crystalline forms and processes for the preparation of cannabinoid receptor modulators. SSHc22 re... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of ulcerative colitis and Crohn's disease |
|
|
P/S
|
Pharmaceutical preparations for treatment of ulcerative colitis, Crohn's disease and dermatologic... |
|
|
Invention
|
3-phenoxyazetidin-1-yl-heteroaryl pyrrolidine derivatives and the use thereof as medicament. The ... |
|
|
P/S
|
pharmaceutical preparations and substances; sanitary preparations for medical purposes. |
|
|
Invention
|
Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of renal cyst... |
|
|
Invention
|
Modulators of the beta-3 adrenergic receptor for the treatment or prevention of renal cystic dise... |
|
|
Invention
|
Substituted (1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the trea... |
|
|
Invention
|
Modulators of the beta-3 adrenergic receptor useful for the treatment or prevention of heart fail... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of autoimmune, inflammatory, gastrointestinal disea... |
|
|
Invention
|
Method of treating conditions related to the pgi2 receptor. Provided in some embodiments are titr... |
|
|
Invention
|
Compounds and methods for treatment of visceral pain.
The present invention relates to certain c... |
|
|
Invention
|
Administration of a compound to individuals with hepatic impairment.
Provided are methods useful... |
|
|
Invention
|
Administration of a compound to individuals with hepatic impairment. Provided are methods useful ... |
|
|
Invention
|
5-ht2c receptor agonists and compositions and methods of use.
Provided in some embodiments are c... |
|
|
Invention
|
Methods of treatment.
Provided are methods of treating or preventing Raynaud's, comprising presc... |
|
|
Invention
|
Methods of treatment. Provided are methods of treating or preventing Raynaud's, comprising prescr... |
|
|
Invention
|
Methods of treatment with selective cb2 receptor agonists.
Provided are methods of treatment of ... |
|
2021
|
Invention
|
Methods of treatment.
Provided are methods for the parenteral use of 3-methoxy-N-[3-(2-methylpyr... |
|
|
Invention
|
Methods of treating conditions related to the s1p1 receptor.
Described herein are methods for tr... |
|
|
Invention
|
Isoxazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of ... |
|
|
Invention
|
Substituted 3-phenoxyazetidin-1-yl-pyrazines. The invention relates to substituted 3-phenoxyazeti... |
|
|
P/S
|
Pharmaceutical preparations for human use to treat ulcerative colitis, diseases and disorders of ... |
|
|
P/S
|
Pharmaceutical preparations for human use to treat
ulcerative colitis, diseases and disorders of... |
|
2020
|
P/S
|
Research and development in the pharmaceutical and biotechnology fields |
|
2019
|
P/S
|
Pharmaceutical preparations for human use; pharmaceutical
preparations for human use to treat ul... |
|
|
P/S
|
Pharmaceutical preparations for human use; pharmaceutical preparations to treat gastrointestinal ... |
|
2007
|
P/S
|
Pharmaceutical preparations and compounds; pharmaceutical
preparations and compounds for the tre... |
|
|
P/S
|
Chemicals; chemical compounds and products, including those for use in biotechnology, drug discov... |
|
|
P/S
|
(( pharmaceutical preparations and pharmaceutical compounds for the treatment of [ metabolic diso... |
|
1999
|
P/S
|
LABORATORY RESEARCH, SCREENING, EVALUATION, DEVELOPMENT AND CLINICAL TESTING OF THERAPEUTIC COMPO... |
|
1998
|
P/S
|
laboratory research services involving G Protein Coupled Receptors (GPCRs), and screening of GPCR... |
